Biomarkers for Alzheimer’s disease beyond amyloid and tau

被引：0
|
作者：
Henrik Zetterberg
Jonathan M. Schott
机构：
[1] Sahlgrenska Academy at the University of Gothenburg,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology
[2] Sahlgrenska University Hospital,Clinical Neurochemistry Laboratory
[3] Department of Neurodegenerative Disease,undefined
[4] UCL Queen Square Institute of Neurology,undefined
[5] UK Dementia Research Institute at UCL,undefined
[6] Dementia Research Centre,undefined
[7] Box 16,undefined
[8] National Hospital for Neurology and Neurosurgery,undefined
来源：
Nature Medicine | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Two new biomarkers for Alzheimer’s disease include one in the blood that relates to neurodegeneration and another that reflects blood–brain barrier dysfunction and is identifiable in cerebrospinal fluid analysis.
引用
收藏
页码：201 / 203
页数：2
相关论文
共 50 条
  • [11] Cerebrospinal fluid amyloid beta and tau protein: biomarkers for Alzheimer's disease
    Mandic, Gorana
    Markovic, Ivanka
    Ostojic, Marija
    Stojkovic, Tanja
    Misirlic-Dencic, Sonja
    Zivanovic-Radnic, Tatjana
    Stefanovic, Rodoljub
    Bumbasirevic, Marko
    Stefanova, Elka
    Kostic, Vladimir
    VOJNOSANITETSKI PREGLED, 2008, 65 (12) : 901 - 905
  • [12] Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease
    Pradeepkiran, Jangampalli Adi
    Baig, Javaria
    Islam, Md Ariful
    Kshirsagar, Sudhir
    Reddy, Hemachandra
    AGING AND DISEASE, 2025,
  • [13] New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
    Feng Zhang
    Ru-jia Zhong
    Cheng Cheng
    Song Li
    Wei-dong Le
    Acta Pharmacologica Sinica, 2021, 42 : 1382 - 1389
  • [14] Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer's disease
    Young-Pearse, Tracy L.
    Lee, Hyo
    Hsieh, Yi-Chen
    Chou, Vicky
    Selkoe, Dennis J.
    TRENDS IN NEUROSCIENCES, 2023, 46 (06) : 426 - 444
  • [15] Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer's Disease Therapeutics
    Dias, Daniela
    Socodato, Renato
    BIOMEDICINES, 2025, 13 (02)
  • [16] New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease
    Zhang, Feng
    Zhong, Ru-jia
    Cheng, Cheng
    Li, Song
    Le, Wei-dong
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (09) : 1382 - 1389
  • [17] Advanced biomarkers: Beyond amyloid and tau: Emerging non-traditional biomarkers for alzheimer`s diagnosis and progression
    Afrin, Meher Rijwana
    Upadhyaya, Pankaj Ghritakousik
    Hashim, Abdul
    Bhattacharya, Kunal
    Chanu, Nongmaithem Randhoni
    Das, Dibyajyoti
    Khanal, Pukar
    Deka, Satyendra
    AGEING RESEARCH REVIEWS, 2025, 108
  • [18] Amyloid biomarkers in Alzheimer's disease
    Blennow, Kai
    Mattsson, Niklas
    Scholl, Michael
    Hansson, Oskar
    Zetterberg, Henrik
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (05) : 297 - 309
  • [19] Alzheimer's disease:: β-amyloid protein and tau
    Morishima-Kawashima, M
    Hara, Y
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) : 392 - 401
  • [20] Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer’s Disease
    S. Duke Han
    Jonathan Gruhl
    Laurel Beckett
    Hiroko H. Dodge
    Nikki H. Stricker
    Sarah Farias
    Dan Mungas
    Brain Imaging and Behavior, 2012, 6 : 610 - 620
12345